Showing results (161-170 of 314) with videos related to

Sort By:
Pageof 32
British Journal of Cancer|May 19, 2021
PALB2 mutations and prostate cancer risk and survivalDominika Wokołorczyk, Wojciech Kluźniak, Klaudia Stempa, et al.
International Journal of Cancer|January 14, 2015
CHEK2 mutations and the risk of papillary thyroid cancerMonika Siołek, Cezary Cybulski, Danuta Gąsior-Perczak, et al.
Biomedicines|February 26, 2025
Copper and Zinc Levels, Prevalence of Common Variants of Genes Involved in Their Metabolism and Psoriasis DiseaseTadeusz Dębniak, Piotr Baszuk, Ewa Duchnik, et al.
BMC Cancer|May 1, 2013
Can selenium levels act as a marker of colorectal cancer risk?Marcin R Lener, Satish Gupta, Rodney J Scott, et al.
Breast Cancer Research and Treatment|November 4, 2005
Prevalence of the NOD2 3020insC mutation in aggregations of breast and lung cancerMarcin Radosław Lener, Dorota Oszutowska, Jennifer Castaneda, et al.
Gene|June 17, 2014
Common variants of xeroderma pigmentosum genes and prostate cancer riskAneta Mirecka, Katarzyna Paszkowska-Szczur, Rodney J Scott, et al.
Genes|July 29, 2023
The APOBEC3B c.783delG Truncating Mutation Is Not Associated with an Increased Risk of Breast Cancer in the Polish PopulationKatarzyna Gliniewicz, Wojciech Kluźniak, Dominika Wokołorczyk, et al.
Hereditary Cancer in Clinical Practice|August 9, 2020
Polymorphisms in MMP-1, MMP-2, MMP-7, MMP-13 and MT2A do not contribute to breast, lung and colon cancer risk in polish populationKatarzyna Białkowska, Wojciech Marciniak, Magdalena Muszyńska, et al.
Cancers|February 25, 2022
Risk of Second Primary Thyroid Cancer in Women with Breast CancerMonika Cieszyńska, Wojciech Kluźniak, Dominika Wokołorczyk, et al.
Pageof 32